SCHEMBL6506738

SCHEMBL6506738

[CH2]NC(=O)c1cc(OC)cc(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
GAA P10253 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.56
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 2/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP1B1 Q16678 1/20 0.51
CASP3 P42574 2/20 0.50
SENP8 Q96LD8 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
SENP6 Q9GZR1 2/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALPL P05186 1/20 0.49
HTT P42858 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9637773 0.83 KDM4E (0.63) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL6497202 0.81 RAB9A (0.68) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL7959771 0.81 PLK1 (0.64) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL6465455 0.81 CA1 (0.64) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL5036685 0.79 CA1 (0.66) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL13527526 0.79 GAA (0.58) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL4589019 0.79 CA1 (0.68) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL6500947 0.79 KDM4E (0.67) KDM4EGAASMN1; SMN2MEN1KMT2A
SCHEMBL7945916 0.78 CYP3A4 (0.55) SMN1; SMN2KMT2AALDH1A1CYP1A1CYP1A2
SCHEMBL8437113 0.78 KDM4E (0.71) KDM4EGAASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
EP-1149072-B1 SULFONAMIDE HYDROXAMATES HOFFMANN LA ROCHE (CH) 2004-06-30 EP disclosed
US-6492394-B1 PROCOLLAGEN C-PROTEINASE INHIBITORS; TREATING FIBROTIC DISEASES SYNTEX (U.S.A.) LLC 2002-12-10 US disclosed
US-6245779-B1 ANALGESICS; ANTIINFLAMMATORY AGENTS OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2001-06-12 US disclosed
CN-1262685-A Naphthyridine derivatives OTSUKA PHARMA CO LTD (JP) 2000-08-09 CN disclosed
EP-0997463-A1 NAPHTHYRIDINE DERIVATIVES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2000-05-03 EP disclosed